Genetic incorporation of a herpes simplex virus type 1 thymidine kinase and firefly luciferase fusion into the adenovirus protein IX for functional display on the virion

被引:40
作者
Matthews, Qiana L.
Sibley, Don A.
Wu, Hongju
Li, Jing
Stoff-Khalili, Mariam A.
Waehler, Reinhard
Mathis, J. Michael
Curiel, David T.
机构
[1] Univ Alabama Birmingham, Dept Med, Div Human Gene Therapy, Birmingham, AL 35294 USA
[2] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA
[3] Univ Alabama Birmingham, Dept Surg, Birmingham, AL 35294 USA
[4] Univ Alabama Birmingham, Dept Obstet & Gynecol, Birmingham, AL 35294 USA
[5] Univ Alabama Birmingham, Gene Therapy Ctr, Birmingham, AL 35294 USA
[6] LSU Hlth Sci Ctr, Dept Cellular Biol & Anat, Gene Therapy Program, Shreveport, LA USA
来源
MOLECULAR IMAGING | 2006年 / 5卷 / 04期
关键词
D O I
10.2310/7290.2006.00029
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
An advantage of the adenoviral vector is its molecular flexibility, which allows for vector tropism modifications for the purpose of cell targeting. In addition to targeting ligands, the capacity to incorporate heterologous pepticles has allowed capsid incorporation of other functionalities. We have defined the minor capsid protein IX (pIX) as a locus capable of presenting incorporated ligands on the virion surface. Thus, we sought to exploit the possibility of incorporating functional proteins at pIX. In our current study, we sought to expand the potential utility of our capsid labeling strategy by developing simultaneous imaging capacity for dedicated small animal positron emission tomography and bioluminescence imaging on a single adenoviral vector. Therefore, we constructed an adenovirus that incorporates a fusion protein of herpes simplex virus type 1 thymidine kinase and firefly luciferase (Luc) (TK-Luc) into adenovirus capsid pIX. Our study herein clearly demonstrates our ability to rescue viable adenoviral particles that display functional TK-Luc as a component of their capsid surface. Most importantly, Ad-plX-TK-Luc retained dual enzymatic functions in vitro and in vivo. This dual-modality approach will allow dynamic or real-time imaging analysis of adenovirus-based interventions with maximized analytic flexibility and enhanced resolution potential.
引用
收藏
页码:510 / 519
页数:10
相关论文
共 32 条
[1]   Direct Comparison of Radiolabeled Probes FMAU, FHBG, and FHPG as PET Imaging Agents for HSV1-tk Expression in a Human Breast Cancer Model [J].
Alauddin, Mian M. ;
Shahinian, Atranik ;
Gordon, Erlinda M. ;
Conti, Peter S. .
MOLECULAR IMAGING, 2004, 3 (02) :76-84
[2]   Targeted adenoviral vectors [J].
Barnett, BG ;
Crews, CJ ;
Douglas, JT .
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION, 2002, 1575 (1-3) :1-14
[3]   Optical imaging of Renilla luciferase reporter gene expression in living mice [J].
Bhaumik, S ;
Gambhir, SS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (01) :377-382
[4]   Avidin-based targeting and purification of a protein IX-modified, metabolically biotinylated adenoviral vector [J].
Campos, SK ;
Parrott, MB ;
Barry, MA .
MOLECULAR THERAPY, 2004, 9 (06) :942-954
[5]   Noninvasive imaging of lentiviral-mediated reporter gene expression in living mice [J].
De, A ;
Lewis, XZ ;
Gambhir, SS .
MOLECULAR THERAPY, 2003, 7 (05) :681-691
[6]  
Everts M, 2004, CURR GENE THER, V4, P337
[7]   Characterization of 911: A new helper cell line for the titration and propagation of early region 1-deleted adenoviral vectors [J].
Fallaux, FJ ;
Kranenburg, O ;
Cramer, SJ ;
Houweling, A ;
VanOrmondt, H ;
Hoeben, RC ;
vanderEb, AJ .
HUMAN GENE THERAPY, 1996, 7 (02) :215-222
[8]   A mutant herpes simplex virus type 1 thymidine kinase reporter gene shows improved sensitivity for imaging reporter gene expression with positron emission tomography [J].
Gambhir, SS ;
Bauer, E ;
Black, ME ;
Liang, QW ;
Kokoris, MS ;
Barrio, JR ;
Iyer, M ;
Namavari, M ;
Phelps, ME ;
Herschman, HR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (06) :2785-2790
[9]   Transductional and transcriptional targeting of adenovirus for clinical applications [J].
Glasgow, JN ;
Bauerschmitz, GJ ;
Curiel, DT ;
Hemminki, A .
CURRENT GENE THERAPY, 2004, 4 (01) :1-14
[10]  
Green Leeta A, 2002, Mol Imaging Biol, V4, P71, DOI 10.1016/S1095-0397(01)00071-1